Barøy, T., Chilamakuri, C. S. R., Lorenz, S., Sun, J., Bruland, Ø. S., Myklebost, O., & Meza-Zepeda, L. A. (2016). Genome Analysis of Osteosarcoma Progression Samples Identifies FGFR1 Overexpression as a Potential Treatment Target and CHM as a Candidate Tumor Suppressor Gene. PLoS One.
Citação norma ChicagoBarøy, Tale, Chandra S. R. Chilamakuri, Susanne Lorenz, Jinchang Sun, Øyvind S. Bruland, Ola Myklebost, and Leonardo A. Meza-Zepeda. "Genome Analysis of Osteosarcoma Progression Samples Identifies FGFR1 Overexpression As a Potential Treatment Target and CHM As a Candidate Tumor Suppressor Gene." PLoS One 2016.
MLA citiranjeBarøy, Tale, et al. "Genome Analysis of Osteosarcoma Progression Samples Identifies FGFR1 Overexpression As a Potential Treatment Target and CHM As a Candidate Tumor Suppressor Gene." PLoS One 2016.